Title : CCDI: a new ligand that modulates mammalian type 1 ryanodine receptor (RyR1).

Pub. Date : 2014 Sep

PMID : 24819467






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 KEY RESULTS: The major product, 2-cyclohexyl-3-cyclohexylimino-2, 3, dihydro-pyrrolo[1,2-c]imidazol-1-one (CCDI) dose-dependently potentiated Ca(2+)-dependent binding of [(3)H]-ryanodine to RyR1, with no significant effects on [(3)H]-ryanodine binding to RyR2 or RyR3. 2-cyclohexyl-3-cyclohexylimino-2,3-dihydropyrrolo(1,2-c)imidazol-1-one ryanodine receptor 3 Homo sapiens